In a patent litigation among medical device manufacturers, CRA was asked to assess damages suffered by plaintiff for alleged infringement of patents on bone compression plates. CRA examined lost profit and reasonable royalty damages, finding that a royalty would have been capped at the cost of implementing a viable non-infringing alternative. CRA provided an expert report and deposition testimony.
Overview of IP litigation in the US involving Chinese companies
This underscores China’s growing commitment to address intellectual property (IP) disputes with foreign entities. While litigators and companies are evaluating...